SEC Form SC 13G/A filed by Keros Therapeutics Inc. (Amendment)
CUSIP No. 492327101
|
Page 2 of 8
|
1
|
NAMES OF REPORTING PERSONS:
|
||
Arkin Bio Ventures Limited Partnership
|
|||
2
|
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP:
|
||
(a)☐
|
|||
(b)☒
|
|||
3
|
SEC USE ONLY:
|
||
|
|||
4
|
CITIZENSHIP OR PLACE OF ORGANIZATION:
Israel |
||
NUMBER OF
SHARES
BENEFICIALLY
OWNED BY
EACH
REPORTING
PERSON
WITH
|
5
|
SOLE VOTING POWER:
|
|
0
|
|||
6
|
SHARED VOTING POWER:
|
||
1,371,074
|
|||
7
|
SOLE DISPOSITIVE POWER:
|
||
0
|
|||
8
|
SHARED DISPOSITIVE POWER:
|
||
1,371,074
|
|||
9
|
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON:
|
||
1,371,074
|
|||
10
|
CHECK IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES:
|
||
☐
|
|||
11
|
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11):
|
||
4.98%*
|
|||
12
|
TYPE OF REPORTING PERSON:
|
||
PN
|
|||
CUSIP No. 492327101
|
Page 3 of 8
|
1
|
NAMES OF REPORTING PERSONS:
|
||
Arkin Bio Venture Partners Ltd.
|
|||
2
|
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP:
|
||
(a)☐
|
|||
(b)☒
|
|||
3
|
SEC USE ONLY:
|
||
|
|||
4
|
CITIZENSHIP OR PLACE OF ORGANIZATION:
Israel |
||
NUMBER OF
SHARES
BENEFICIALLY
OWNED BY
EACH
REPORTING
PERSON
WITH
|
5
|
SOLE VOTING POWER:
|
|
0
|
|||
6
|
SHARED VOTING POWER:
|
||
1,371,074
|
|||
7
|
SOLE DISPOSITIVE POWER:
|
||
0
|
|||
8
|
SHARED DISPOSITIVE POWER:
|
||
1,371,074
|
|||
9
|
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON:
|
||
1,371,074
|
|||
10
|
CHECK IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES:
|
||
☐
|
|||
11
|
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11):
|
||
4.98%*
|
|||
12
|
TYPE OF REPORTING PERSON:
|
||
CO
|
|||
CUSIP No. 492327101
|
Page 4 of 8
|
1
|
NAMES OF REPORTING PERSONS:
|
||
Moshe Arkin
|
|||
2
|
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP:
|
||
(a)☐
|
|||
(b)☒
|
|||
3
|
SEC USE ONLY:
|
||
|
|||
4
|
CITIZENSHIP OR PLACE OF ORGANIZATION:
Israel |
||
NUMBER OF
SHARES
BENEFICIALLY
OWNED BY
EACH
REPORTING
PERSON
WITH
|
5
|
SOLE VOTING POWER:
|
|
0
|
|||
6
|
SHARED VOTING POWER:
|
||
1,371,074
|
|||
7
|
SOLE DISPOSITIVE POWER:
|
||
0
|
|||
8
|
SHARED DISPOSITIVE POWER:
|
||
1,371,074
|
|||
9
|
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON:
|
||
1,371,074
|
|||
10
|
CHECK IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES:
|
||
☐
|
|||
11
|
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11):
|
||
4.98%*
|
|||
12
|
TYPE OF REPORTING PERSON:
|
||
IN
|
|||
CUSIP No. 492327101
|
Page 5 of 8
|
Item 1.
|
(a)
|
Name of Issuer:
Keros Therapeutics, Inc.
|
(b)
|
Address of Issuer's Principal Executive Offices:
50 Hampshire Street, Suite 401
Cambridge, MA 02139
|
Item 2.
|
(a)
|
Name of Person Filing:
Arkin Bio Ventures Limited Partnership
Arkin Bio Venture Partners, Ltd.
Moshe Arkin
|
(b)
|
Address of Principal Business Office:
6 Ha’Choshlim St., Building C, 6th Floor
Herzliya Pituach 46724 Israel |
(c)
|
Citizenship or Place of Incorporation:
Israel
|
(d)
|
Title of Class of Securities:
Common Stock, par value $0.0001 per share
|
(e)
|
CUSIP Number:
492327101
|
Item 3.
|
Not applicable.
|
Item 4.
|
Ownership:
|
(a)
|
Amount beneficially owned:
See row 9 of cover page of each reporting person.
|
CUSIP No. 492327101
|
Page 6 of 8
|
(b)
|
Percent of class:
See row 11 of cover page of each reporting person
|
(c)
|
Number of shares as to which such person has:
|
(i)
|
Sole power to vote or to direct the vote:
See row 5 of cover page of each reporting person
|
(ii)
|
Shared power to vote or to direct the vote:
See row 6 of cover page of each reporting person and note in Item 4(a) above
|
(iii)
|
Sole power to dispose or to direct the disposition of:
See row 7 of cover page of each reporting person
|
(iv)
|
Shared power to dispose or to direct the disposition of:
See row 8 of cover page of each reporting person and note in Item 4(a) above
|
Item 5.
|
Ownership of Five Percent or Less of a Class:
|
CUSIP No. 492327101
|
Page 7 of 8
|
Item 6.
|
Ownership of More than Five Percent on Behalf of Another:
|
Item 7.
|
Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person:
|
Item 8.
|
Identification and Classification of Members of the Group:
|
Item 9.
|
Notice of Dissolution of Group:
|
|
Arkin Bio Ventures Limited Partnership
By its General Partner, Arkin Bio Venture Partners, Ltd.
|
|
/s/ Moshe Arkin
Name: Moshe Arkin
Title: Director
Arkin Bio Venture Partners, Ltd.
|
|
/s/ Moshe Arkin
Name: Moshe Arkin
Title: Director
|
|
/s/ Moshe Arkin
Moshe Arkin
|